Home LiteratureArticle Details
PMID: 9971814 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Identification of retroviral late domains as determinants of particle size.

Journal of virology ·Vol. 73 ·No. 3 ·1999-03-00 ·Pages 2309-20

Garnier L, Parent LJ, Rovinski B, Cao SX, Wills JW

Abstract

Retroviral Gag proteins, in the absence of any other viral products, induce budding and release of spherical, virus-like particles from the plasma membrane. Gag-produced particles, like those of authentic retrovirions, are not uniform in diameter but nevertheless fall within a fairly narrow distribution of sizes. For the human immunodeficiency virus type 1 (HIV-1) Gag protein, we recently reported that elements important for controlling particle size are contained within the C-terminal region of Gag, especially within the p6 sequence (L. Garnier, L. Ratner, B. Rovinski, S.-X. Cao, and J. W. Wills, J. Virol. 72:4667-4677, 1998). Deletions and substitutions throughout this sequence result in the release of very large particles. Because the size determinant could not be mapped to any one of the previously defined functions within p6, it seemed likely that its activity requires the overall proper folding of this region of Gag. This left open the possibility of the size determinant residing in a subdomain of p6, and in this study, we examined whether the late domain (the region of Gag that is critical for the virus-cell separation step) is involved in controlling particle size. We found that particles of normal size are produced when p6 is replaced with the totally unrelated late domain sequences from Rous sarcoma virus (contained in its p2b sequence) or equine infectious anemia virus (contained in p9). In addition, we found that the large particles released in the absence of p6 require the entire CA and adjacent spacer peptide sequences, whereas these internal sequences of HIV-1 Gag are not needed for budding (or proper size) when a late domain is present. Thus, it appears the requirements for budding are very different in the presence and absence of p6.

MeSH Terms
Animals COS Cells Capsid/physiology Gene Products, gag/physiology HIV-1/physiology Nucleocapsid/physiology Particle Size Retroviridae/physiology Viral Matrix Proteins/physiology Virion/physiology
Chemicals
Gene Products, gag Viral Matrix Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Garnier L
Departments of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA.
Parent L J
Rovinski B
Cao S X
Wills J W
References (39)
39 references, click to expand
  1. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences.
    J Virol. 1992 Apr;66(4):1856-65 PMID: 1548743
  2. Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src.
    J Virol. 1991 Jul;65(7):3804-12 PMID: 1710290
  3. Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly.
    J Virol. 1991 Nov;65(11):6205-17 PMID: 1717718
  4. Functional domains of HIV-1 gag-polyprotein expressed in baculovirus-infected cells.
    Virology. 1991 Sep;184(1):417-22 PMID: 1871977
  5. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.
    Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9 PMID: 2014240
  6. Ubiquitin in avian leukosis virus particles.
    Virology. 1990 Jun;176(2):633-7 PMID: 2161153
  7. Incorporation of chimeric gag protein into retroviral particles.
    J Virol. 1990 Sep;64(9):4169-79 PMID: 2166812
  8. Biological techniques for avian sarcoma viruses.
    Methods Enzymol. 1979;58:379-93 PMID: 218076
  9. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.
    Proc Natl Acad Sci U S A. 1989 Nov;86(22):8964-7 PMID: 2479031
  10. Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells.
    J Virol. 1989 Oct;63(10):4331-43 PMID: 2550669
  11. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells.
    Cell. 1989 Oct 6;59(1):103-12 PMID: 2676191
  12. Arthrin, a myofibrillar protein of insect flight muscle, is an actin-ubiquitin conjugate.
    Cell. 1987 Oct 23;51(2):221-8 PMID: 2822254
  13. Ubiquitin is a component of the microtubule network.
    Proc Natl Acad Sci U S A. 1988 May;85(9):3019-23 PMID: 2834729
  14. Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.
    Proc Natl Acad Sci U S A. 1988 Sep;85(18):6944-8 PMID: 3413127
  15. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
    J Virol. 1995 Nov;69(11):6810-8 PMID: 7474093
  16. Interaction of tyrosine-based sorting signals with clathrin-associated proteins.
    Science. 1995 Sep 29;269(5232):1872-5 PMID: 7569928
  17. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins.
    J Virol. 1995 Sep;69(9):5455-60 PMID: 7636991
  18. Ubiquitin is conjugated to the cytoskeletal protein alpha-spectrin in mature erythrocytes.
    J Biol Chem. 1995 Apr 14;270(15):8928-35 PMID: 7721801
  19. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity.
    J Virol. 1995 Jun;69(6):3407-19 PMID: 7745687
  20. Myosin-actin interaction plays an important role in human immunodeficiency virus type 1 release from host cells.
    Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2026-30 PMID: 7892219
  21. An assembly domain of the Rous sarcoma virus Gag protein required late in budding.
    J Virol. 1994 Oct;68(10):6605-18 PMID: 8083996
  22. The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency.
    J Virol. 1994 Oct;68(10):6782-6 PMID: 8084015
  23. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.
    J Virol. 1994 Mar;68(3):1689-96 PMID: 8107229
  24. Role of the cytoskeleton in cell-to-cell transmission of human immunodeficiency virus.
    J Virol. 1994 May;68(5):2898-905 PMID: 8151760
  25. Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.
    J Virol. 1994 Jan;68(1):111-22 PMID: 8254720
  26. Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release.
    J Virol. 1993 Sep;67(9):5550-61 PMID: 8394460
  27. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins.
    J Virol. 1993 Nov;67(11):6487-98 PMID: 8411352
  28. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Virology. 1993 Feb;192(2):605-17 PMID: 8421902
  29. Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis.
    Cell. 1996 Jan 26;84(2):277-87 PMID: 8565073
  30. WW domains and retrovirus budding.
    Nature. 1996 Jun 27;381(6585):744-5 PMID: 8657277
  31. HIV-1 Gag protein associates with F-actin present in microfilaments.
    Virology. 1996 Jun 15;220(2):530-4 PMID: 8661406
  32. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions.
    J Virol. 1996 Nov;70(11):7734-43 PMID: 8892894
  33. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle.
    J Virol. 1996 Dec;70(12):8645-52 PMID: 8970990
  34. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein.
    J Virol. 1997 Sep;71(9):6541-6 PMID: 9261374
  35. Genetic determinants of Rous sarcoma virus particle size.
    J Virol. 1998 Jan;72(1):564-77 PMID: 9420260
  36. Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus.
    J Virol. 1998 Apr;72(4):2962-8 PMID: 9525617
  37. Particle size determinants in the human immunodeficiency virus type 1 Gag protein.
    J Virol. 1998 Jun;72(6):4667-77 PMID: 9573230
  38. Recent advances and remaining problems in HIV assembly.
    AIDS. 1998;12 Suppl A:S5-16 PMID: 9632979
  39. Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly.
    J Virol. 1998 Dec;72(12):10218-21 PMID: 9811764
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1999-03-00
Pages
2309-20
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC104476
Subset
IM
Grants
NCI NIH HHS · R01 CA047482 · United States
NCI NIH HHS · R37 CA047482 · United States
NIAID NIH HHS · AI01148 · United States
NCI NIH HHS · CA47482 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]